What does Johnson & Johnson do?

Johnson & Johnson (JNJ) is a Pharmaceuticals company. Johnson & Johnson sells Innovative Medicine (Darzalex, Tremfya, Carvykti, and a shrinking Stelara franchise) and MedTech (surgery, orthopaedics, cardiovascular, and vision). It has announced an intent to separate Orthopaedics as DePuy Synthes. It was founded in 1886, is headquartered in New Brunswick, New Jersey and employs about 138,200 people.

How does Johnson & Johnson make money?

As of 2026-Q2, Johnson & Johnson's revenue breaks down across Innovative Medicine (65%), MedTech (35%). See the revenue-by-segment chart for the full mix.

How has Johnson & Johnson's revenue and profitability trended?

Track Johnson & Johnson's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.

Who are Johnson & Johnson's main competitors?

Sterling groups Johnson & Johnson in the Healthcare sector, alongside Bristol Myers Squibb (BMY), Viatris (VTRS) and Zoetis (ZTS).

If I'm investing in Johnson & Johnson, what similar companies should I consider?

If you are researching Johnson & Johnson, also look at Bristol Myers Squibb (BMY), Viatris (VTRS) and Zoetis (ZTS). You can compare all of them side by side or browse the full Healthcare sector on Sterling.